Establishment Labs Holdings Inc.
NASDAQ:ESTAMedical - Devices
+$2.65 today
- Market cap
- $2.11B
- Beta
- 1.11
- P/E (TTM)
- -57.6
- EPS (TTM)
- -$1.48
Volume 0.38M
Average 0.50M
ESTA Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Establishment Labs Holdings Inc.NASDAQ: ESTA
Revenue · Q3 FY2026 · quarter ended Sep 2026
Revenue grows, but more slowly than its trailing trend
Q3 FY2026 revenue of $71.99M rose 33.9% year over year, behind the +38.3% change in trailing-twelve-month revenue. Sequentially, it rose 6.6% from the prior quarter. Over 3 fiscal years it compounded at +9.3% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 7 analysts of $274.8M (+30.2%) for the fiscal year ending Dec 2026, a step up from the +27.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $71.99M+6.6% QoQ
- Last fiscal yearDec 2025
- $211.08M+27.1% YoY
- LTMSep 2026
- $264.03M+38.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +33.9% | +16.6% | -17.3 pp |
| 1 year | +27.1% | +30.2% | +3.1 pp |
| 3-year CAGR | +9.3% | +26.1% | +16.8 pp |
| 5-year CAGR | +25.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 211.08M USD
- Year-over-year change
- +27.1%
- 4-year CAGR
- +13.6%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 211.08M | +27.1% |
| FY2024 | 2024-12-31 | 166.03M | +0.5% |
| FY2023 | 2023-12-31 | 165.15M | +2.1% |
| FY2022 | 2022-12-31 | 161.7M | +27.6% |
| FY2021 | 2021-12-31 | 126.68M | — |
Revenue vs competitors
How ESTA compares with its peers on the latest reported figures
- ESTA's LTM Sep 2026 revenue of $264.03M is the 3rd highest of the 4 companies compared; the peer median is $374.64M.
- Its year-over-year change of +38.3% is the highest of 4, against a peer median of +1.2%.
- Over three fiscal years its annual growth of +9.3% compares with a peer median of +1.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1.64B | +1.2% | +1.6% | |
| LTM Mar 2026 | $374.64M | -4.5% | -6.6% | |
| LTM Sep 2026 | $264.03M | +38.3% | +9.3% | |
| LTM Jun 2026 | $79.91M | +6.1% | +24.7% | |
| Peer median (excluding ESTA) | $374.64M | +1.2% | +1.6% | |
Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 126.68M | 161.7M | 165.15M | 166.03M | 211.08M |
| Cost of Revenue | 41.28M | 55.11M | 58.17M | 56.5M | 64.77M |
| Gross Profit | 85.4M | 106.6M | 106.98M | 109.53M | 146.31M |
| Gross Margin | 67.4% | 65.9% | 64.8% | 66.0% | 69.3% |
| Research & Development | 18.32M | 20.27M | 26.43M | 19.71M | 20.25M |
| Selling, General & Admin | 92.23M | 125.98M | 145.58M | 139.81M | 165.07M |
| Operating Expenses | 110.54M | 146.25M | 172M | 159.51M | 185.32M |
| Depreciation & Amortization | 4.12M | 4.34M | 4.88M | 7.58M | 10.47M |
| EBITDA | (26.53M) | (56.73M) | (58.31M) | (56.22M) | (22.29M) |
| EBITDA Margin | -20.9% | -35.1% | -35.3% | -33.9% | -10.6% |
| Operating Income | (25.14M) | (39.66M) | (65.03M) | (49.99M) | (39.01M) |
| Operating Margin | -19.8% | -24.5% | -39.4% | -30.1% | -18.5% |
| Interest Income | 23K | 87K | 1.02M | 1.48M | 423K |
| Interest Expense | 9.06M | 11.76M | 15.39M | 20.83M | 25.26M |
| Other Income / Expenses | (14.57M) | (33.17M) | (13.56M) | (34.64M) | (19.01M) |
| Income Before Tax | (39.71M) | (72.82M) | (78.58M) | (84.63M) | (58.02M) |
| Pre-Tax Margin | -31.3% | -45.0% | -47.6% | -51.0% | -27.5% |
| Income Tax Expense | 1.43M | 2.39M | (81K) | (32K) | (6.96M) |
| Net Income | (41.14M) | (75.21M) | (78.5M) | (84.6M) | (51.06M) |
| Net Margin | -32.5% | -46.5% | -47.5% | -51.0% | -24.2% |
| EPS (Basic) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| EPS (Diluted) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| Weighted Avg Shares | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
| Weighted Avg Shares (Diluted) | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
Establishment Labs Holdings Inc.
NASDAQ:ESTA
Intrinsic Alpha fair value
Locked
Current Price
$70.80
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.